Drug · DIN 02567059
TEPADINA
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since March 27, 2026.
- Drug Identification Number (DIN)
- 02567059
- Company (DIN owner)
- Adienne SaLugano, Tessin, Switzerland
- Schedule
- Prescription
- Dosage form
- Powder For Solution
- Route
- Intravenous
- Therapeutic class (ATC)
- Thiotepa L01AC01
- Class
- Human
- Record last updated
- August 5, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| THIOTEPA | 200 MG | BAG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 27, 2026: NOC 37201Supplement to a New Drug Submission (SNDS) · Addition of new strength: 200 mg/bag. Change in the specification for the drug product. Change in the labelled storage conditions for drug product
Other DINs named TEPADINA
- DIN 02462680 · Marketed
- DIN 02462702 · Marketed
- DIN 02523906 · Dormant